Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Asker Healthcare Group AB ( (SE:ASKER) ) just unveiled an announcement.
Asker Healthcare Group has announced the acquisition of Van Heek Medical, a prominent manufacturer and distributor of medical supplies in the Benelux region. This strategic move is expected to enhance Asker’s presence in the region and contribute positively to the company’s EBITA margin, following regulatory approvals expected in early 2026.
The most recent analyst rating on (SE:ASKER) stock is a Buy with a SEK107.00 price target. To see the full list of analyst forecasts on Asker Healthcare Group AB stock, see the SE:ASKER Stock Forecast page.
More about Asker Healthcare Group AB
Asker Healthcare Group is a European healthcare company that partners with caregivers and patients to provide medical products and solutions. The group focuses on improving patient outcomes, reducing the total cost of care, and ensuring a sustainable value chain. With over 4,500 employees across 19 countries, Asker Healthcare Group generates revenues of SEK 16 billion.
Average Trading Volume: 1,210,915
Technical Sentiment Signal: Strong Sell
Current Market Cap: SEK33.05B
For detailed information about ASKER stock, go to TipRanks’ Stock Analysis page.